Muhammad Zohaib Khan. FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR. J Popl Ther Clin Pharmacol [Internet]. 2024 Sep. 25 [cited 2025 Sep. 14];31(9):4104-28. Available from: https://www.jptcp.com/index.php/jptcp/article/view/10033